Medicalg Net Assets

Latest as of March 2026: zł62.94 Million PLN ≈ $17.32 Million USD

Medicalg net assets. Based on the latest financial reports, Medicalg (MDG) has net assets worth zł62.94 Million PLN (≈ $17.32 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł111.36 Million ≈ $30.65 Million USD) and total liabilities (zł48.42 Million ≈ $13.33 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how fast is Medicalg growing its equity to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	zł62.94 Million
% of Total Assets	56.52%
Annual Growth Rate	23.19%
5-Year Change	36.38%
10-Year Change	-69.93%
Growth Volatility	150.15

Net Assets of Medicalg (2010–2025)

Net assets of Medicalg from 2010 to 2025. This chart illustrates how Medicalg's net assets have evolved over time, based on quarterly financial data. See Medicalg (MDG) net asset quality to measure how much of total assets are equity-financed.

Annual Net Assets for Medicalg (2010–2025)

The table below shows the annual net assets of Medicalg from 2010 to 2025. For live market cap and overall valuation, see Medicalg market cap and net worth.

Year	Net Assets	Change
2025-12-31	zł64.64 Million ≈ $17.79 Million	-16.26%
2024-12-31	zł77.19 Million ≈ $21.24 Million	-16.62%
2023-12-31	zł92.57 Million ≈ $25.48 Million	+15.59%
2022-12-31	zł80.08 Million ≈ $22.04 Million	+68.96%
2021-12-31	zł47.39 Million ≈ $13.04 Million	-77.14%
2020-12-31	zł207.37 Million ≈ $57.07 Million	-7.72%
2019-12-31	zł224.72 Million ≈ $61.85 Million	-2.62%
2018-12-31	zł230.76 Million ≈ $63.51 Million	+13.27%
2017-12-31	zł203.73 Million ≈ $56.07 Million	-5.22%
2016-12-31	zł214.95 Million ≈ $59.16 Million	+116.71%
2015-12-31	zł99.19 Million ≈ $27.30 Million	+9.25%
2014-12-31	zł90.79 Million ≈ $24.99 Million	+12.19%
2013-12-31	zł80.93 Million ≈ $22.27 Million	+9.63%
2012-12-31	zł73.82 Million ≈ $20.32 Million	+521.22%
2011-12-31	zł11.88 Million ≈ $3.27 Million	+319.97%
2010-12-31	zł2.83 Million ≈ $778.68K	--

Equity Component Analysis

This analysis shows how different components contribute to Medicalg's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 14428363382.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Medicalg Net Assets Breakdown (December 2025)

Medicalg net assets breakdown by equity component as of December 2025.

Component	Amount	Percentage
Common Stock	zł995.00K	1.54%
Other Comprehensive Income	zł208.05 Million	321.95%
Other Components	zł720.00K	1.11%
Total Equity	zł64.62 Million	100.00%

Medicalg Competitors by Market Cap

The table below lists competitors of Medicalg ranked by their market capitalization.

Company	Market Cap
EQL PHARMA AB F:7JK	$59.21 Million
Inversa Prime SOCIMI S.A. MC:YIPS	$59.22 Million
Newfield Resources Ltd AU:NWF	$59.24 Million
Comtrend Corp TWO:8089	$59.26 Million
Camus Engineering & Construction Inc KO:013700	$59.12 Million
Yong Pyong Resort Corp KO:070960	$59.11 Million
Thai Wacoal Public Company Limited BK:WACOAL	$59.10 Million
Greenheart Gold Inc. V:GHRT	$59.08 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Medicalg's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 77,174,000 to 64,620,999, a change of -12,553,001 (-16.3%).
Net loss of 11,684,000 reduced equity.
Other comprehensive income increased equity by 209,392,999.
Other factors decreased equity by 210,262,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	zł-11.68 Million	-18.08%
Other Comprehensive Income	zł209.39 Million	+324.03%
Other Changes	zł-210.26 Million	-325.38%
Total Change	zł-	-16.27%

Book Value vs Market Value Analysis

This analysis compares Medicalg's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 3.33x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 19.03x to 3.33x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2010-12-31	zł1.14	zł21.60	x
2011-12-31	zł4.77	zł21.60	x
2012-12-31	zł25.67	zł21.60	x
2013-12-31	zł23.65	zł21.60	x
2014-12-31	zł26.27	zł21.60	x
2015-12-31	zł28.70	zł21.60	x
2016-12-31	zł49.06	zł21.60	x
2017-12-31	zł46.83	zł21.60	x
2018-12-31	zł52.64	zł21.60	x
2019-12-31	zł54.29	zł21.60	x
2020-12-31	zł50.11	zł21.60	x
2021-12-31	zł10.42	zł21.60	x
2022-12-31	zł16.61	zł21.60	x
2023-12-31	zł17.50	zł21.60	x
2024-12-31	zł7.75	zł21.60	x
2025-12-31	zł6.49	zł21.60	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Medicalg utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -18.08%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -37.71%
• Asset Turnover: 0.28x
• Equity Multiplier: 1.72x
Recent ROE (-18.08%) is below the historical average (-15.50%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2010	67.51%	46.50%	1.12x	1.30x	zł1.63 Million
2011	25.30%	51.78%	0.43x	1.13x	zł1.82 Million
2012	10.08%	67.86%	0.15x	1.02x	zł57.08K
2013	13.44%	69.27%	0.19x	1.03x	zł2.78 Million
2014	16.00%	48.89%	0.31x	1.05x	zł5.45 Million
2015	14.04%	28.23%	0.48x	1.03x	zł4.01 Million
2016	22.66%	31.35%	0.35x	2.09x	zł22.41 Million
2017	15.12%	12.56%	0.70x	1.71x	zł8.65 Million
2018	7.59%	7.23%	0.63x	1.66x	zł-4.57 Million
2019	-0.15%	-0.17%	0.61x	1.45x	zł-19.88 Million
2020	-6.23%	-11.56%	0.39x	1.37x	zł-33.65 Million
2021	-381.21%	-373.61%	0.42x	2.41x	zł-185.38 Million
2022	-12.53%	-18.91%	0.58x	1.15x	zł-21.33 Million
2023	-0.62%	-1.34%	0.35x	1.31x	zł-9.83 Million
2024	-20.84%	-67.00%	0.23x	1.37x	zł-23.80 Million
2025	-18.08%	-37.71%	0.28x	1.72x	zł-18.15 Million

Industry Comparison

This section compares Medicalg's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $51,812,926
Average return on equity (ROE) among peers: -46.50%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Medicalg (MDG)	zł62.94 Million	67.51%	0.77x	$59.17 Million
Adiuvo Investment SA (ADV)	$51.55 Million	-101.96%	0.30x	$2.02 Million
Braster S.A. (BRA)	$5.92 Million	-50.98%	0.07x	$4.69 Million
Genomtec S.A. (GMT)	$8.30 Million	-108.56%	0.92x	$10.55 Million
Medinice S.A (ICE)	$3.26 Million	-15.53%	0.50x	$144.91 Million
Synektik S.A. (SNT)	$190.02 Million	44.54%	0.97x	$756.78 Million

About Medicalg

WAR:MDG Poland Medical Devices

Market Cap

$59.17 Million

zł214.98 Million PLN

Market Cap Rank

#21052 Global

#180 in Poland

Share Price

zł21.60

Change (1 day)

-3.57%

52-Week Range

zł21.60 - zł36.90

All Time High

zł343.35